Kinetic studies of novel inhibitors of endomorphin degrading enzymes

Endomorphins (EMs), two endogenous μ-opioid receptor selective ligands, are attractive lead compounds for opioid-based pain management studies. However, these peptides are quickly degraded by peptidases, in particular by dipeptidylpeptidase IV (DPP IV) and aminopeptidase M (APM). Targeting enzymatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Perlikowska, Renata, Fichna, Jakub, do-Rego, Jean Claude, Gach, Katarzyna, Janecka, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359464/
https://www.ncbi.nlm.nih.gov/pubmed/22707871
http://dx.doi.org/10.1007/s00044-011-9666-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359464/
https://www.ncbi.nlm.nih.gov/pubmed/22707871
http://dx.doi.org/10.1007/s00044-011-9666-5

Ejemplares similares